Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Brave Bison in talks to buy MiniMBA from Centaur Media

(Sharecast News) - Shares in Brave Bison rose strongly on Friday after the media, market and tech group confirmed press speculation that it is set to buy marketing elearning business MiniMBA from Centaur Media. MiniMBA, founded by well-known marketing guru Mark Ritson, provides MBA-level tuition through an online learning platform to around 6,000 people each year, having trained nearly 40,000 professional since it started. It is used by individual marketers, as well big corporates like John Lewis, Nestle and Tesco when training their marketing teams.

Brave Bison said it has entered into exclusive negotiations with Centaur Media to buy the business for an enterprise value of £19m.

Brave Bison's stock was up nearly 6% at 2.7p by 0846 GMT, having now gained around 30% since the start of 2025. Centaur Media was rising nearly 11% to 29.31p.

Brave Bison said MiniMBA will form the "cornerstone" of a new elearning and business intelligence division, and will involve cross-selling to the company's existing client base.

"Whilst the parties remain in exclusive negotiations in respect of the potential acquisition until 19 June 2025, there can be no certainty that the acquisition will conclude nor the terms on which any acquisition will conclude. Further announcements will be made, as appropriate, in due course," Brave Bison said in a statement.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.